Stockwinners Market Radar for September 14, 2021 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

19:01 EDT Rio Tinto, Caterpillar partner over zero-emissions autonomous trucks - Rio Tinto (RIO) and Caterpillar (CAT) have signed a Memorandum of Understanding for Caterpillar's development of zero-emissions autonomous haul trucks for use at one of Rio Tinto's Western Australian mining operations. The collaboration will see Rio Tinto work with Caterpillar to advance the development of the manufacturer's future 220-tonne 793 zero-emissions autonomous haul truck including the validation of Caterpillar's emerging zero-emissions technology. Rio Tinto and Caterpillar will progress a series of development milestones to include a 793 prototype pilot program, testing and pre-production trials. It is anticipated that the world's first operational deployment of approximately 35 new Caterpillar 793 zero-emissions autonomous haul trucks will be at Gudai-Darri once development is complete.

18:39 EDT Microsoft raises quarterly dividend 11% to 62c per share - Microsoft announced that its board of directors declared a quarterly dividend of 62c per share, reflecting a 6c or 11% increase over the previous quarter's dividend. The dividend is payable Dec. 9, 2021, to shareholders of record on Nov. 18, 2021. The ex-dividend date will be Nov. 17, 2021.

18:18 EDT Ubisoft delays 'Rocksmith+' release to 2022 - Ubisoft said that its upcoming video game "Rocksmith+," a virtual guitar learning service, will be delayed until 2022. "We will use this opportunity to incorporate user feedback from our Closed Beta," the company said. "We are convinced that this new release plan will give us time to deliver a smooth experience for all guitar and bass lovers."

17:37 EDT Regeneron announces HHS, DoD purchase 1.4M additional doses of REGEN-COV - Regeneron Pharmaceuticals announced that the U.S. Department of Health and Human Services, HHS, and the Department of Defense, DoD, will purchase 1.4M additional doses of REGEN-COV. The government will continue to provide REGEN-COV at no cost to patients. Under the new agreement, Regeneron will supply an additional 1.4M 1,200 mg doses of REGEN-COV to the U.S. government by January 31, 2022, at a cost of $2,100 per dose. This new agreement follows two earlier agreements with the U.S. government announced in July 2020 and January 2021. REGEN-COV is an investigational medicine authorized by the FDA under an emergency use authorization to treat people who are at high risk of serious consequences from COVID-19 infection who are either already infected or in certain post-exposure prophylaxis settings.

17:21 EDT Broadcom COO Charlie Kawwas sells $1.5M in company shares - Broadcom COO Charlie Kawwas disclosed in a filing that he had sold 3,000 shares of company stock at $500.83 per share on September 10, for a total transaction value of $1,502,491.

17:10 EDT Regeneron awarded $2.94B Army contract modification for 1.4M REGEN-COV doses - Regeneron was awarded a $2.94B modification to a contract for 1.4M REGEN-COV antibody therapeutic doses. Work will be performed in Tarrytown, New York, with an estimated completion date of July 31, 2022. FY21 research, development, test and evaluation, Army funds in the amount of $2.94B were obligated at the time of the award. U.S. Army Contracting Command is the contracting activity.

16:41 EDT Atlas Crest Investment shareholders approve deal with Archer Aviation - Atlas Crest Investment Corp. (ACIC), a special purpose acquisition company, announced that its stockholders approved all proposals related to the previously announced business combination with Archer Aviation Inc. (ACHR) at a special meeting of stockholders held today. A Current Report on Form 8-K disclosing the full voting results will be filed with the Securities and Exchange Commission. Approximately 96% of votes cast at the Special Meeting voted to approve the Business Combination. In connection with the vote on the Business Combination, approximately 48.5% of eligible shareholders exercised redemption rights. The Business Combination will generate approximately $857.6M of gross proceeds, including $600M of proceeds from the PIPE. The closing of the Business Combination is anticipated to occur on or about September 16, 2021. Following the closing, the combined company will be known as "Archer Aviation Inc." and its common stock and warrants are expected to trade on the New York Stock Exchange under the new ticker symbols "ACHR" and "ACHR WS," respectively, on September 17, 2021.

16:31 EDT American Financial Group declares $4.00 per share special dividend - American Financial Group announced that it has declared a special, one-time cash dividend of $4.00 per share of American Financial Group Common Stock. The dividend is payable on October 5 to holders of record on September 28. The aggregate amount of the payment to be made in connection with this special dividend will be approximately $340M. This special dividend is in addition to the company's regular quarterly cash dividend last paid in July 2021. AFG recently announced a 12% increase in its regular quarterly cash dividend to 56c per share, beginning in October.

16:18 EDT International Paper declares spin-off distribution of Sylvamo common stock - International Paper (IP) announced that, in connection with its previously announced separation and spin-off of its global papers business, International Paper's board of directors declared a pro rata distribution of approximately 80.1% of the outstanding shares of Sylvamo (SLVM) common stock to be made effective at 12:01 a.m. New York City time on October 1 to International Paper's shareholders of record as of 5:00 p.m. New York City time on September 15, the previously-announced record date for the distribution. Each International Paper shareholder will receive one share of Sylvamo common stock for every eleven shares of International Paper common stock held on the record date. Following the distribution, International Paper will own approximately 19.9% of the outstanding shares of Sylvamo common stock. International Paper shareholders will not receive fractional shares of Sylvamo common stock. Instead, fractional shares of Sylvamo common stock will be aggregated and sold in the open market, with the net proceeds distributed pro rata in cash payments to the International Paper shareholders who would otherwise receive a fractional share of Sylvamo common stock. Sylvamo common stock began trading on a "when-issued" basis on the NYSE under the symbol "SLVM WI" on September 14. On October 1, "regular way" trading under the symbol "SLVM" is expected to begin. The CUSIP number for the Sylvamo common stock will be 871332 102 when regular way trading begins.

16:13 EDT Ibex sees FY22 022 organic revenue growth of 7%- 9% - Fiscal Year 2022 organic revenue growth of 7% to 9%. Revenue growth will accelerate beginning in the second quarter as we onboard new capacity in Q1.

16:09 EDT FTC Solar CEO Tony Etnyre to step down, Sean Hunkler to succeed - FTC Solar announced that Tony Etnyre will step down as CEO and member of the board. The board has appointed Sean Hunkler as his successor effective September 24. Etnyre will continue to support the company on strategic matters and business development through a transition period reaching into 2022. Hunkler joins FTC Solar from Western Digital Corporation where he serves as executive VP of global operations, overseeing all aspects of global activities including providing leadership to more than 62,000 people across a network including 18 factories. Prior to joining Western Digital in 2018, Hunkler had significant semiconductor and solar experience, including serving as EVP of Global Operations for NXP Semiconductors, and then COO of its spin-off company, Nexperia. Prior to those positions, he held senior leadership roles at SunEdison/MEMC Electronic Materials, Freescale Semiconductor and Motorola.

16:07 EDT AAR in exclusive commercial aviation distribution pact with Arkwin Industries - AAR has signed an exclusive distribution agreement with Arkwin Industries. The agreement covers Arkwin's broad line of engine actuation and commercial aviation products for the commercial aviation aftermarket and is effective as of October 1. "We are excited to partner with AAR as our new aftermarket partner for our commercial aviation business," said Kristian Norheim, Arkwin Vice President of Sales & Marketing. "We are confident that Arkwin's realignment of aftermarket support capabilities using AAR will allow Arkwin to more effectively support our global customer base." "We are thrilled to add Arkwin's products to our portfolio and look forward to working with its team to provide market intelligence and grow its footprint," said Eric Young, AAR Senior Vice President of OEM Solutions. "This agreement provides meaningful growth to AAR's OEM Solutions business and the CFM56, CF34, and CF6 products complement our existing engine offering."

16:06 EDT Darling Ingredients says restart of Diamond Green Diesel in Louisiana underway - Darling Ingredients is issuing the following statement regarding its joint venture Diamond Green Diesel, located in Norco, Louisiana. "The restart of Diamond Green Diesel in Norco, Louisiana is underway and normal operations are anticipated in the next few days. DGD's 400 million gallon renewable diesel expansion project remains on track to be fully operational by the middle of the fourth quarter of 2021."

16:04 EDT Amgen and The Lundquist Institute announce Diadem received on year of lab space - Amgen and The Lundquist Institute announced that Diadem Biotherapeutics has been awarded the first Amgen Golden Ticket in Southern California. Diadem will receive one year of lab space at BioLabs LA at The Lundquist Institute, or TLI, as well as additional facility benefits and connections to Amgen's scientific and business leaders. The 2021 Amgen Golden Ticket winner was chosen by an internal team of Amgen scientific leaders at a virtual pitch event. Five finalists pitched their business plans before Amgen's internal committee that evaluated the strength and novelty of their scientific rationale, subject matter expertise and business plan viability.

16:01 EDT Raytheon Intelligence & Space to acquire SEAKR Engineering - Raytheon Technologies has signed a definitive agreement to acquire privately-held SEAKR Engineering, a supplier of advanced space electronics. Closure of the acquisition is subject to the completion of customary conditions and regulatory approvals. SEAKR Engineering will be a wholly-owned subsidiary of Raytheon Technologies and will report into Raytheon Intelligence & Space upon closing.

15:37 EDT Calliditas announces PDUFA goal date extension for Nefecon NDA - Calliditas Therapeutics announced that the U.S. Food and Drug Administration has extended the PDUFA goal date for its New Drug Application, or NDA, seeking accelerated approval for Nefecon to December 15, 2021. "Our NDA for Nefecon is the first time that the FDA is considering an approval on the basis of proteinuria as a surrogate endpoint for accelerated approval in IgA nephropathy, requiring an in-depth review process. We will continue to cooperate closely with the FDA as they complete the review of our NDA," said Renee Aguiar-Lucander, CEO at Calliditas. "In its review of the NDA, the FDA has requested further analyses of the NeflgArd trial data which the company has provided to the FDA. The Agency has classified these analyses as a major amendment to the NDA. The amendment mainly provides additional eGFR and other related analyses as further support of the proteinuria data provided in the NDA submission," the company added.

15:16 EDT Morgan Stanley COO says NII guidance given in Q2 'still holds' - Morgan Stanley COO Jonathan Pruzan, speaking at the Barclays Financial Services conference, stated: "I think on NII, I mean, the guidance that we gave in the second quarter still holds. The curve hasn't -- I'm trying to think from June 30. It hasn't really done very much. Obviously, we continue to see good loan growth, which should lead to, again, in small increments, generally a positive trajectory on NII. But until we see sort of major movements either in short-term rates or the shape of the curve, we're going to be sort of in the state where we've been for the last couple of quarters." Asked about the company's plans to update its two-year and longer-term ROTCE targets, Pruzan responded: "So no big reveal. I think you know we do our targets once a year in January, and we're going to do them again in January, and I don't want to get ahead of that, and I certainly don't want to contradict anything Boss has said. But I think you'll hear, and I'm assuming we're going to talk about the acquisitions and the underlying strength of the businesses, but we're really optimistic for a variety of reasons."

15:07 EDT Ping Identity appoints Jason Kees as chief information security officer - Ping Identity (PING) appointed Jason Kees as the company's new chief information security officer, or CISO. He will spearhead Ping Identity's security initiatives. Kees most recently served as vice president and chief information security officer at Groupon (GRPN), where he built the enterprise security organization from the ground up. Additionally, Jason had oversight for the online marketplace's IT and engineering operations teams of several hundred people.

15:03 EDT Full Sail IP Partners buys Odwalla from Coca-Cola - Full Sail IP Partners, an acquiror of leading brands, announced it has acquired the Odwalla brand from the Coca-Cola Company. "We're thrilled that Odwalla, with its long history of innovation, high levels of brand awareness and reputation for great products, will be our first acquisition. We look forward to providing consumers with the best tasting, artfully crafted functional beverages and foods to allow them to snack well, feel well and live well," said Alan Kravetz, Full Sail's CEO.

14:31 EDT Spire reports FERC issues temporary certificate for STL Pipeline - The Federal Energy Regulatory Commission, or FERC, has issued a temporary certificate authorizing the continued operation of Spire STL Pipeline for 90 days, "a first step in keeping the STL Pipeline in service ahead of this winter," Spire announced. Scott Smith, president of the Spire STL Pipeline, said: "This temporary certificate provides additional time to meaningfully engage with all stakeholders on the need for STL Pipeline without the threat of customers in Eastern Missouri losing the energy they rely on. Having said that, this authorization does not get us through what can be some of winter's coldest months," says Smith. "We stand ready to work with all parties, including FERC, to achieve continued energy security for the people of the St. Louis region. Keeping the STL Pipeline in service will ensure that Spire Missouri customers have the energy needed to heat homes and water, cook food and fuel industry... The issuance of this temporary certificate provides the Commission with the requisite time to conduct a thorough review of our July 26 application and the additional information that we submitted on August 6, 2021. We will continue to fully cooperate with the FERC and other stakeholders to ensure they have the information needed to complete a comprehensive review of our application. In the long term, we are confident that when people have an opportunity to review the proven benefits of the STL Pipeline and current market conditions they will agree that there is a critical need for this infrastructure to ensure continued access to reliable, affordable energy for homes and businesses in the greater St. Louis region."

14:20 EDT Apple announces iPhone 13 Pro, iPhone 13 Pro Max - Apple introduced the iPhone 13 Pro and iPhone 13 Pro Max. Both models introduce an all-new Super Retina XDR display with ProMotion featuring an adaptive refresh rate up to 120Hz, making the touch experience faster and more responsive. iPhone 13 Pro and iPhone 13 Pro Max also include 5G with more bands for better coverage, big improvements to battery life for the best battery life ever on iPhone with iPhone 13 Pro Max, new storage capacity of 1TB, and the Ceramic Shield front cover, tougher than any smartphone glass. Pre-orders begin Friday, September 17, with availability beginning Friday, September 24. Customers can get iPhone 13 Pro for $999 and iPhone 13 Pro Max for $1,099.

14:18 EDT Apple announces Watch Series 7 with 18-hour battery life - Apple announced Apple Watch Series 7, "featuring a reengineered Always-On Retina display with significantly more screen area and thinner borders, making it the largest and most advanced display ever." The company added, "The narrower borders allow the display to maximize screen area, while minimally changing the dimensions of the watch itself. The design of Apple Watch Series 7 is refined with softer, more rounded corners, and the display has a unique refractive edge that makes full-screen watch faces and apps appear to seamlessly connect with the curvature of the case." Apple Watch Series 7 provides all-day 18-hour battery life on a single charge, and 33% faster charging compared with Apple Watch Series 6. All Apple Watch Series 7 models will be available later this fall. Apple Watch Series 7 will start at $399, Apple Watch SE starts at $279, and Apple Watch Series 3 starts at $199.

14:05 EDT Crocs announces new Accelerated Share Repurchase plan - Crocs announced that it expects to have repurchased $500M of shares in 2021 by the end of the fiscal third quarter. In addition, the company announced it will enter into a new Accelerated Share Repurchase, or "ASR," plan that will conclude by the end of 2021, which will bring total expected repurchases by year end to $1B. Earlier this month, the board of directors approved an increase to the company's repurchase authorization such that $1.05B will remain available for future common stock repurchases after the announced ASR is completed, Crocs noted.

13:56 EDT Apple says iPhone 13 Mini starts at $699, regular iPhone 13 starts at $799 - Says iPhone 13 comes with upgraded 5G capabilities tow ork in 60 countries and regions. Says iPhone 13 comes with better battery life, 2.5 hours longer than iPhone 12. Says iPhone 13 starts at $799, with iPhone 13 Mini starting at $699. Says starting capacity for iPhone 13 increased to 128GB, adding 512GB option as well.

13:40 EDT Apple unveils iPhone 13

13:37 EDT Apple introduces ninth generation iPad with A13 Bionic chip - Apple introduced the new iPad, "featuring the powerful A13 Bionic chip that packs even more performance and capability into the most popular iPad, all while retaining its all-day battery life.1 Starting at just $329, the new iPad features a 10.2-inch Retina display with True Tone, a 12MP Ultra Wide front camera with Center Stage, support for Apple Pencil and Smart Keyboard, the intuitive iPadOS 15, and twice the storage of the previous generation. The new iPad is available to order beginning today on apple.com, and in stores beginning Friday, September 24." "iPad has never been more essential for working, learning, and communicating, and we're excited to bring one of the biggest updates ever to our most popular iPad," said Greg Joswiak, Apple's senior vice president of Worldwide Marketing. "With the powerful A13 Bionic, more engaging video calls with Center Stage, and double the storage, the new iPad delivers advanced capabilities, versatility, and simplicity at an incredible value."

13:35 EDT Apple unveils new iPad mini with larger 8.3-inch liquid retina display - Apple introduced the powerful new iPad mini with a larger 8.3-inch Liquid Retina display - in four finishes. Apple said: "Featuring the brand new A15 Bionic chip, the new iPad mini delivers up to 80 percent faster performance than the previous generation, making it the most capable iPad mini ever. A new USB-C port allows faster connectivity, and cellular models with 5G bring more flexible mobile workflows. New advanced cameras, Center Stage, and support for Apple Pencil enable new ways for users to capture photos and videos, communicate with loved ones, and jot down their ideas when creativity strikes. The new iPad mini is available to order beginning today, and will be in stores beginning Friday, September 24."

13:21 EDT Apple says new iPad Mini starts at $499, available next week - Says new iPad Mini comes with USB-C port, enabling 10x faster data transfers than predecessor. Says new iPad Mini to support 5G networking. Says comes with new speaker system with stereo in landscape mode and Center Stage support. Says starts at $499, available next week.

13:15 EDT Apple introduces new iPad Mini - Says iPad Mini getting "biggest upgrade ever." Says new iPad Mini has new all-screen design that is "remarkbly thin and light." Says iPad Mini now comes in four colors and features liquid retina display. Says new iPad Mini comes with secure touch ID and a "remarkable" performance upgrade, including a 40% jump in CPU performance and 80% increase in GPU performance.

13:09 EDT Apple unveils new entry-level iPad - Says "proud" that Apple TV+ has 35 Emmy nominations. Says iPad "more popular and more essential than ever." Says "just getting started" with Apple TV+. Says new entry-level iPad comes with A13 bionic chip. Says A13 "leaps ahead" of competition. Comments taken from Apple Keynote event.

12:34 EDT Gaucho Group to acquire additional real estate assets in Argentina in $2.4M deal - Gaucho Group Holdings announced that its shareholders had approved the purchase of additional land holdings in Argentina in an all-stock transaction valued at approximately $2.4M. The purchase price was determined from an evaluation of the real estate performed by an independent third-party. Located in Argentina, the properties were acquired from the related, but independent entity, Hollywood Burger Holdings. One of the property lots is located in the San Rafael, Mendoza region of Argentina, and the other in Cordoba, Argentina, with the estimated fair market value of the combined properties totaling approximately $2.4M. Both properties are located on major thoroughfares, seeing significant foot and street traffic, and both with ample parking, a feature considered a rare benefit in Argentine cities.

12:32 EDT VivoPower announces multi-national distribution deal for Tembo e-LVs - VivoPower International announced that the Company has signed a definitive agreement with GHH Group for GHH to distribute Tembo powered electric light vehicles in over 50 countries across Africa, Asia, Europe and the Americas, using e-LV conversion kits from VivoPower's wholly-owned subsidiary Tembo e-LV B.V. Under the agreement, GHH intends to purchase 3,000 Tembo e-LV conversion kits through to December 2026. GHH will be responsible for acquiring original vehicles from Toyota, converting the vehicles to ruggedized e-LVs using the Tembo conversion kits, selling the Tembo powered e-LVs to end-customers and providing ongoing servicing and maintenance. . With the execution of this contract, VivoPower can now offer Tembo powered e-LVs to customers on six continents as the Company continues to advance its aim to build a global Tembo distribution network before the end of this calendar year.

12:00 EDT Las Vegas Sands falls -13.0% - Las Vegas Sands is down -13.0%, or -$5.58 to $37.31.

12:00 EDT Herbalife Nutrition falls -16.7% - Herbalife Nutrition is down -16.7%, or -$9.08 to $45.16.

12:00 EDT RYB Education rises 10.9% - RYB Education is up 10.9%, or 31c to $3.19.

11:53 EDT DBV Technologies jumps 5% to $5.30 after SocGen upgrades to Buy

11:44 EDT PNC Financial CEO sees NII 'a little bit soft" in Q3, fees outperforming

11:40 EDT U.S. video game spending grew 7% y/y in August, says NPD - NPD analyst Mat Piscatella said that August 2021 consumer spending across video game hardware, content and accessories grew 7% when compared to a year ago, to an August record $4.4B. YTD consumer spending totaled $37.9B, a 13% increase when compared to the same period in 2020. Hardware was a primary driver of spending gains in August. Led by Sony's (SONY) PS5, hardware dollar sales gained 45% when compared to August 2020. Mobile and Subscription pushed August content spending higher when compared to a year ago. August video game hardware dollar sales gained 45% when compared to August 2020, to $329M. This is the highest total achieved in a August month since 2008, and the third highest August month total in history. Year-to-date hardware spending has increased 49% when compared to the same period in 2020, totaling $3B. Nintendo Switch (NTDOY) was the best-selling hardware platform in units during both the August month and year-to-date, while PlayStation 5 leads both time periods in dollar sales. After 10 months in market PlayStation 5 remains the fastest selling PlayStation platform in history, Piscatella said. Other companies in the gaming space include Microsoft (MSFT), Tencent (TCEHY), Electronic Arts (EA), Take-Two (TTWO), Activision Blizzard (ATVI), Ubisoft (UBSFY), GameStop (GME), and Capcom (CCOEY). Reference Link

11:40 EDT Crocs up 12% to $154.31 as 2026 'ambition' discussed at investor day - Shares of Crocs are up about 12% in late morning trading as the company hosts its 2021 investor day meeting. During the event, the company discussed an "ambition" to grow sales from $2.25B in 2021 to over $5B in 2026, which it notes implies a 17%-plus compound annual growth rate.

11:33 EDT Ameresco selected by City of Mesquite, Texas for AMI system - Ameresco announced that it has been selected by the City of Mesquite, Texas to install a comprehensive smart metering infrastructure improvement project for its residential and commercial water utility customers. The project will include the installation of solid-state water meters and an advanced metering infrastructure system to allow for wireless reading of water usage data to replace the current manual reading of meters. Ameresco will replace more than 42,000 water meters and 41,000 meter boxes citywide. At the end of the first year, the city is expected to accrue operational savings. The project is expected to be completed in the next two years.

11:18 EDT Wells Fargo 'affirms focus on building strong risk and control foundation' - Wells Fargo issued a press release in which it said it has affirmed its "focus on building [a] strong risk and control foundation." The bank stated in part: "Serving customers with the highest standards requires a strong risk and control foundation. That's why meeting our own expectations for risk management and controls - as well as our regulators' - remains Wells Fargo's top priority. We are a different bank today than we were five years ago because we've made significant progress." The company, which outlined steps taken since 2019, also stated that it has "achieved several important regulatory milestones over the past two years, which are indicative of our progress," listing that in September 2021, the CFPB consent order issued in September 2016 regarding improper retail sales practices was terminated; in January 2021, the OCC terminated a 2015 Consent Order related to Wells Fargo's Bank Secrecy Act/Anti-Money Laundering compliance program; and in May 2020, the OCC upgraded Wells Fargo's Community Reinvestment Act rating to "outstanding."

11:09 EDT Cinedigm appoints John Canning as CFO - Cinedigm announced that John Canning has joined the Company as CFO, effective September 13, 2021. Canning will report to Chris McGurk, Chairman & CEO, and will be responsible for all financial functions at Cinedigm to support and enhance the Company's rapid growth trajectory. Prior to Cinedigm, Canning spent two years as the CFO of Firefly Systems Inc., an Ad-Tech startup in Silicon Valley, where he worked to secure funding, working capital and equipment financing.

10:58 EDT Zimmer Biomet says 'more likely' to be toward bottom end of FY21 guidance range

10:57 EDT Zimmer Biomet: Delta putting pressure on elective procedures - Says "not immune" to the recent slowdown and that the Delta variant is putting pressure on elective procedures. Comments taken from the Baird Global Healthcare Conference.

10:37 EDT AT&T CFO: Options in WarnerMedia deal include split, spinoff - CFO Pascal Desroches notes that the company "can do a combination of both."

10:03 EDT Izea reports 115% year-over-year growth in Q3 Managed Services Bookings to date - IZEA Worldwide announced that it has been awarded a variety of contracts from both new and existing clients, propelling IZEA's Managed Services Bookings to top 115% growth in Q3 2021 to date, as compared to Q3 2020. Managed Services Bookings for the quarter are currently $8.5M as compared to $4M in 2020, already making it the best Q3 in company history with half the month of September remaining. This is IZEA's third consecutive quarter of triple digit growth for Managed Services Bookings.

10:00 EDT Herbalife Nutrition falls -12.9% - Herbalife Nutrition is down -12.9%, or -$6.98 to $47.26.

10:00 EDT Invacare rises 7.1% - Invacare is up 7.1%, or 46c to $6.95.

10:00 EDT RYB Education rises 11.1% - RYB Education is up 11.1%, or 32c to $3.20.

09:47 EDT Herbalife Nutrition falls -11.4% - Herbalife Nutrition is down -11.4%, or -$6.18 to $48.06.

09:47 EDT North American Construction rises 7.4% - North American Construction is up 7.4%, or $1.04 to $15.14.

09:47 EDT IronNet rises 9.3% - IronNet is up 9.3%, or $1.81 to $21.20.

09:42 EDT JPMorgan seeing strength in equities, 'a little less' in FICC, says Lake

09:41 EDT JPMorgan's Lake: Future reserve releases to be 'much more modest'

09:37 EDT Knight-Swift launches Iron Truck Services organization - Knight-Swift Transportation announced that it has launched Iron Truck Services, an organization that brings together services essential to transportation carriers and includes insurance, equipment maintenance, fuel purchasing, and truck sales and rentals. Iron Trucks Services provides affordable solutions to truckload carriers by leveraging the scale and infrastructure of the nation's largest carrier, Knight-Swift. Iron Truck Services includes the following offerings: IRON INSURANCE, which provides auto, general, and cargo liability insurance, as well as physical damage insurance options at affordable rates. All policies are supported by risk management services that promote safe operational practices for policyholders. IRON FUEL PROGRAM, which is a free membership program providing access to a discount network of over 1,500 fueling locations nationwide, with savings, credit lines, fuel tax filing, and other benefits. IRON MAINTENANCE, which offers wholesale prices, free DOT inspections, and maintenance services at 19 locations nationwide, with additional locations planned to open before the end of the year. IRON TRUCK SALES & RENTALS, which offers a wide selection of used, DOT qualified trucks and equipment at 30 locations nationwide.

09:27 EDT Sanofi completes acquisition of Translate Bio - Sanofi announced the completion of its acquisition of Translate Bio, further accelerating the company's efforts to develop transformative vaccines and therapies using mRNA technology. The acquisition adds a critical pillar to the company's mRNA Center of Excellence which aims to unlock the potential of next-generation mRNA vaccines and other strategic areas such as immunology, oncology, and rare diseases. The tender offer for all of the outstanding shares of Translate Bio common stock expired as scheduled at one minute after 11:59 p.m., Eastern Time, on Monday, September 13, 2021. The minimum tender condition and all of the other conditions to the offer have been satisfied and on September 14, 2021, Sanofi accepted for payment and will promptly pay for all shares validly tendered and not validly withdrawn. Following its acceptance of the tendered shares, Sanofi completed its acquisition of Translate Bio through the merger of a wholly owned subsidiary of Sanofi with and into Translate Bio, pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with Translate Bio continuing as the surviving corporation and becoming an indirect, wholly owned subsidiary of Sanofi. In connection with the merger, all Translate Bio shares not validly tendered in the tender offer have been converted into the right to receive the same $38 per share in cash, without interest thereon and net of any applicable withholding taxes, that would have been paid had such shares been validly tendered in the tender offer. As of September 14, 2021, Translate Bio common stock will cease to be traded on the NASDAQ Global Select Stock Market.

09:24 EDT Leidos selects Nuance's AI technology - Nuance Communications (NUAN) announced that Leidos (LDOS) will use Nuance's AI technology as part of their scalable and customizable digital patient engagement solutions for health systems and federal healthcare agencies. Using the Nuance Mix conversational AI development platform, the same technology leveraged by the world's leading banks, telecommunications companies, and retailers to create superior customer experiences, Leidos will help customers accelerate IT modernization, enhance patient experiences, and improve care costs and outcomes.

09:20 EDT Tyler Technologies signs 10-year pact with Colorado's DORA - Tyler Technologies announced it has signed a 10-year agreement with the Colorado Department of Regulatory Agencies , DORA, Division of Professions and Occupations, for Tyler's ETK Regulatory solution. Tyler will provide the agency with an integrated licensing regulation management platform to help it offer as many licensing services online as possible to expand public access without compromising the quality of data. "We are excited to upgrade our licensing regulation management with the help of Tyler's technology," said DORA's Ronne Hines, division director, Division of Professions and Occupations. "By offering more licensing services online, it will put our customers in control of accessing these crucial services. Additionally, it will free up some of our staff resources to focus on other critical tasks." DORA is the state of Colorado's umbrella regulatory agency, charged with managing licensing and registration for multiple professions and businesses, implementing balanced regulation for Colorado industries, and protecting consumers...Tyler will partner with the state to provide the initial investment to implement the solution. DORA will then collect transaction fees from its constituents to fund the system over the term of the contract.

09:19 EDT Compass to acquire LegacyTexas Title insurance service - Compass announced that it has signed a definitive agreement to acquire LegacyTexas Title, a leading title insurance company serving Dallas-Fort Worth. The acquisition will significantly strengthen the company's growing portfolio of title and escrow businesses. The transaction is contingent upon regulatory approval and is expected to close before the end of the year. The terms of the deal are not being disclosed. In February of this year Compass announced the acquisition of Washington D.C. area title insurance and settlement services company, KVS Title.

09:14 EDT Peak Fintech Group acquires assets of Huayan Kun Tai Technology - Peak Fintech Group announced that it has acquired the assets of Huayan Kun Tai Technology Company, a private company that provides various SaaS solutions to insurers and insurance brokers in China. Huayan provides its solutions primarily through its proprietary "Heartbeat" insurance product management and brokerage platform, where users pay a subscription fee to access the services plus a commission-related service fee when applicable. All of Huayan's assets, including the Heartbeat platform, its employees and its operations will be transferred to Peak's Xinxiang Technologies Ltd. subsidiary, which was created in the Q2 specifically to help bring insurance related products and services to members of Peak's Business Hub. The Heartbeat platform saw a significant increase in the number of insurance brokerage companies using it in 2021 with the number of users going from 8 at the end of 2020 to 420 by the end of August 2021. As compensation for the acquisition of Huayan's operations, Peak will pay Huayan and its shareholders a total of $31.0M, of which $11.0M will be payable in cash to be used by Huayan in various capacities to position Xinxiang for success as Huayan winds down its operations and transfers them to Xinxiang. The remaining $20.0M will be payable to Huayan's shareholders in common shares of Peak, of which $6.0M will be payable within ten business days of the signing of the agreement and $14.0M will be payable over a three-year period based on certain net income targets to be achieved by Xinxiang during that period.

09:12 EDT Rite Aid debuts 'remote-first work approach for corporate associates' - Rite Aid unveiled its "corporate workplace of the future - a remote-first work approach for corporate associates, supported by a network of collaboration centers throughout the company's geographic footprint. The reimagined workplace model focuses on flexibility for associates, while also creating an official headquarters space in Philadelphia designed specifically for in-person collaboration and company gatherings, rather than office spaces," the company said. Rite Aid CEO Heyward Donigan, who championed the initiative to redefine the company's approach to work, announced the transformation in a video to the enterprise-wide corporate team this morning. The new enterprise headquarters will be located in Philadelphia's vibrant Navy Yard district, offering a modern space for teams across Rite Aid's various businesses - including Rite Aid retail, Elixir, Health Dialog and Bartell Drugs - to meet, collaborate, engage clients and partners, and cultivate the kind of strong professional relationships that serve as the bedrock for successful remote teams. Additionally, planned regional collaboration centers across the country will provide opportunities for Rite Aid teams to come together for in-person meetings, training and development, and more.

09:10 EDT Berry Global to invest $110M + in North American foodservice packaging - Berry Global Group announced plans to expand its foodservice packaging manufacturing operations in North America as part of its long-term strategic growth commitments. This more than $110M investment will expand its proprietary and industry-leading polypropylene thermoforming capabilities to manufacture clear drink cups and lids for quick-service restaurants, coffee shops, convenience stores, and other foodservice markets. The clear design fills an increasing demand for a cup that showcases a premium brand image and beverage appeal and improves restaurant operation efficiencies while offering a more sustainable packaging option. Foodservice brand owners are steadily increasing their forecasted volumes with Berry production for access to the Company's 30-plus active patents across clear cups and lids. In addition, customized plastic cup and lid brand owner solutions are a rapidly increasing market trend, pulling volume from alternative substrates since 2017. As a result, Berry has demonstrated its market leadership, outpacing market trends growing its sales by a forecasted 60%*.

09:07 EDT American International Holdings' EPIQ MD launches online healthcare platform - American International Holdings announced its subsidiary EPIQ MD, Inc., has launched its online healthcare platform bringing its comprehensive suite of telemedicine services to the estimated more than 80 million Americans who are uninsured, or underserved by traditional health insurance. These services include primary medical and mental health care, preventative health and wellness programs, medical advocacy, discounted prescriptions and much more. EPIQ MD has the advantage of having been conceived and developed as a low-cost digital telemedicine company -- not a digital extension of a traditional brick & mortar HMO trying to lower their fixed cost of delivery. EPIQ MD was designed to offer low-priced, high-value services to fill the largest gaps in the US healthcare system with its entry into the estimated $36.6 billion North American telemedicine marketplace.

09:07 EDT Anika Therapeutics's Tacpset Injectable Bone Substitute cleared by FDA - Anika Therapeutics announced that it has received an additional 510(k) clearance by the FDA for Tactoset Injectable Bone Substitute. This new indication expands the use of Tactoset to include augmentation of hardware and the support of bone fragments during surgical procedures. This expands Tactoset's addressable market to include augmentation of suture anchor fixation in addition to treatment of skeletal system defects such as insufficiency fractures. "Poor quality bone and suture anchor pullout is a real problem for patients in our industry, and surgeons can now use Tactoset to augment their suture anchor fixation and reinforce it from inside the bone. We've taken our proprietary HA-enhanced Tactoset and opened an untapped market in the area of augmentation of hardware including soft tissue suture anchors," says Ben Joseph, Vice President of US Commercial and Global Brand Management at Anika. Tactoset is a calcium phosphate based, biocompatible bone graft substitute that incorporates Anika's core hyaluronic acid technology. Anika expects to begin actively marketing the expanded indication for Tactoset for hardware augmentation in October 2021.

09:05 EDT Senmiao Technology signs new contract with Shanghai Lutuan Technology - Senmiao Technology announced the signing of a new contract with Shanghai Lutuan Technology, an affiliate of Meituan, China's leading e-commerce platform for services focused on its "Food + Platform" strategy. According to this new cooperation agreement, online ride-hailing requests and orders will be completed on Meituan's platform utilizing Senmiao's network of cars and drivers for a set monthly fee. This new agreement will have no impact on drivers' incomes, and drivers' incentives will be paid by the major platform going forward.

09:04 EDT WynnBET named an official sports betting partner of the New York Jets - WynnBET announced on Tuesday a partnership with the New York Jets naming the operator as an Official Sports Betting partner of the team. The multi-year agreement includes the entitlement of the WynnBET Green Room at MetLife Stadium for Jets gamedays as well as presenting partnership of the Jets Podcast Network and the Jets SportsNet NY Pre and Post Game Live shows. The centerpiece of the relationship is the WynnBET Green Room, a ticketed, 21 years-old and over all-inclusive food and beverage hospitality space at Jets home games. The luxury club space, approximately 4,800 square feet, will provide an immersive sportsbook experience, allowing ticketed Jets fans access to live WynnBET betting content such as point spreads, game totals, in-play wagering and more.

09:03 EDT GSE Systems awarded contract by nuclear power plant operator - GSE Systems has been awarded a contract from a large US nuclear 3-unit power plant operator to deliver a web-based Thermal System Monitoring, or TSM, Program using GSE's proprietary technology and Data Validation and Reconciliation, or DVR, modeling expertise The contract combines GSE TrueNorth's Thermal System Monitoring technology, TSM Enterprise, with DVR capabilities pioneered by partner Belsim. Innovative solutions like TSM Enterprise and DVR are in great demand as the nuclear industry looks to improve the performance of aging nuclear reactor plants while reducing non-fuel costs. The software solution will provide the operator with the ability to monitor and report thermal performance, identify degraded components, and troubleshoot thermal performance problems.

09:01 EDT Skye Bioscience announces special virtual investor presentation - Skye Bioscience announced that it will host a special virtual investor presentation on Tuesday, October 12. The filmed broadcast of this virtual event will be available beginning at 1 p.m. ET/10:00 a.m. PT. The agenda will include the company's strategic direction and business outlook for 2022, clinical development updates on the company's lead glaucoma program, R&D advancements and new initiatives, followed by Q&A. Speakers for this event will include Skye's executive management team in addition to select members of its scientific and clinical advisory boards.

08:48 EDT U.S. Gold announces land agreement to grant access to develop CK Gold Project - U.S. Gold announced it has entered into a land agreement with the surrounding land-owner that provides an option to lease additional land and grant access necessary to develop the CK Gold Project. The CK Gold Project is located in the mining-friendly state of Wyoming, 20 miles west of Cheyenne. U.S. Gold controls two Wyoming state leases that make up the CK Gold Project. Prior to this land agreement, the Company gained access to the project through an annual easement agreement with the local rancher, who is the primary landowner to the north and east of the CK Gold Project. The new agreement allows for an additional access route into the project off County Road 210, approximately two miles off the paved Happy Jack Road from the west. The mine development is expected to include new water resources that could eventually be used for irrigation and additional livestock watering, electrical infrastructure to power wells and pumps, and new fencing and roads to better access and utilize ranchlands.

08:41 EDT Spottrade to leverage Nasdaq surveillance technology - Nasdaq and Sporttrade, a Philadelphia-based fintech, sports betting company, announced that Sporttrade will leverage Nasdaq technology for surveillance of its sports betting and trading platform. In utilizing Nasdaq's SaaS-deployed market surveillance technology, Sporttrade will be able to monitor trading patterns and protect its user base by identifying irregularities and unusual trading behavior. Through interactive visualization, complex data can be distilled into a single snapshot and provide a full view of the order book, enabling Sporttrade to transparently and continuously collaborate with regulators. "Today marks another important step in fulfilling our mission to elevate the sports betting industry with proven capital markets technology that will monitor our platform and protect our user base," said Alex Kane, Founder and CEO of Sporttrade. "Adopting Nasdaq's industry-leading market surveillance technology is essential in Sporttrade's promise to our participants - to advance fair, transparent, and efficient open sports betting markets." Nasdaq's end-to-end market technology powers more than 2,300 companies in 50 countries, spanning the world's financial industry, including capital markets infrastructure operators, market participants, banks, and regulators. Sporttrade is due to launch its native trading app beginning in New Jersey in Q4 of 2021, with additional states to follow in 2022 and beyond.

08:39 EDT Genasys, Shooter Detection Systems partner to provide active shooter warnings - Genasys (GNSS) announced an integrated technologies partnership with the gunshot detection provider, Shooter Detection Systems, an Alarm.com (ALRM) company, for early gunshot detection and real-time alerting of staff, personnel and the public through the Company's unified Genasys Emergency Management solution. Richard Danforth, Chief Executive Officer of Genasys, said "The integration of GEM with SDS' Guardian Indoor Active Shooter Detection System enhances our critical event management solution and broadens our addressable enterprise and public safety market applications. Seamless integration with SDS provides a unique, customizable solution for delivering life-safety messages through multiple channels immediately after a gunshot."

08:37 EDT Daxor presents new data on BVA-100 blood test - Daxor announces new data validating the benefits of the company's BVA-100 blood test in optimizing individualized therapy for heart failure patients. Data were presented at the Heart Failure Society of America Annual Scientific Meeting 2021 - which brought together the world's leading experts in heart failure from September 10-13, 2021, in Denver, CO. "We continue to add to the clinical evidence demonstrating that the BVA-100 blood test uniquely allows physicians to understand underlying heart failure blood volume derangements, driving better treatment choices and superior outcomes," commented Michael Feldschuh, CEO of Daxor Corporation. "HFSA provided us with a significant opportunity to share these clinical data with leading physicians active in providing care for heart failure patients along with details of newly-enrolling clinical trials by Daxor with major healthcare system partners." Highlights of the data included: "Value of Blood Volume Analysis in Patients with Left Ventricular Assist Devices": Lead study author Dmitry M. Yaranov, M.D., Baptist Heart Institute, Memphis, TN concluded, "In summary, blood volume analysis and its individualized, unique metrics is a valuable test when used in patients with LVAD. Measurement of red blood cell volume is helpful in determining variations that might not be noted clinically, and patient and clinician acceptance and adoption of BVA was excellent." "Volume-Guided Venous to Venous Ultrafiltration in Hospitalized Heart Failure Patients": This pilot study combined blood volume analysis and ultrafiltration to safely remove fluid with volume overload. Study authors indicated that earlier utilization of the BVA-100 test may have prevented the acute renal injury from their previous diuresis. "The Phenotype of Polycythemia and Hypervolemia in Hospitalized Heart Failure Patients": The BVA-100 test was instrumental in better understanding heart failure patients who present with polycythemia, or excess red cells, a condition that may affect 11% of hospitalized heart failure patients that currently goes largely undiagnosed, noted study authors. Two poster presentations were made on the landmark clinical trials by Daxor initiated in 2021 and currently underway, including a National Institute of Health-funded randomized, multicenter, controlled trial with the U.S. Department of Veterans Affairs applying BVA-100-guided care to improve hospitalized heart failure outcomes, a patient population of more than one million. Equally important is an outpatient prospective randomized trial for heart failure management featuring next-generation technology developed through contracts awarded by the U.S. Department of Defense and funded by the Center for Advancing Point of Care Technologies/NIH. This study also measures the benefit of the BVA-100 test for improving ambulatory heart failure patient care, a population that numbers more than 6 million in the U.S. alone.

08:34 EDT OSI Systems receives $3M order for patient monitoring solutions - OSI Systems announced that its Healthcare division, Spacelabs Healthcare, received an order valued at approximately $3M to provide patient monitoring solutions and related accessories to a Midwestern U.S. based hospital. The Company is expected to provide Xhibit Central Stations, Xprezzon patient monitors, and Qube patient monitors. "We are excited to receive this order and look forward to providing our advanced patient monitoring products that help deliver critical patient care," commented Deepak Chopra, OSI Systems' Chairman and CEO.

08:33 EDT Agiliti to acquire Sizewise Rentals for $230M - Agiliti announced that it has entered into a definitive agreement to acquire Sizewise Rentals, a manufacturer and distributor of specialty hospital beds, surfaces and patient handling equipment, in a stock purchase transaction valued at $230M or approximately 7.7x adjusted EBITDA for the twelve months ended June 30. Agiliti intends to finance the transaction through a combination of cash and debt. The boards of directors of both companies have unanimously approved the agreement. Subject to the satisfaction of customary closing conditions, the transaction is expected to close early in Q4. Following the close of the transaction, Agiliti will provide an update to its FY21 financial guidance at the time it reports quarterly results for the period ending September 30. Sizewise is a manufacturer and provider of specialized bed frames, therapeutic surfaces and mobility equipment serving more than 3,000 customers in the acute and post-acute care markets with products that address the needs of bariatric, geriatric, pediatric and standard patient populations. For the twelve months ended June 30, the business generated revenues of $155M and adjusted EBITDA of $30M, inclusive of an estimated benefit from COVID-19 of approximately $5M in adjusted EBITDA. Sizewise is headquartered in Kansas and operates a 24/7 nationwide network of 65 local, in-market service branches and four manufacturing centers.

08:33 EDT Code Chain announces LOI to acquire certain assets including Filecoin servers - Code Chain New Continent announced that it entered into a non-binding letter of intent, or LOI, with Shenzhen Jindeniu Electronics. Pursuant to the LOI, Code Chain agrees to purchase certain assets, including Filecoin, or FIL, servers, FIL digital currency PiB computing power, and FIL digital currency from Jindeniu. The total purchase price will be approximately $15.9M, payable in cash. Following the LOI's execution, Code Chain will arrange its personnel, representatives, and advisors to perform due diligence on the Target Assets. Upon completion of the due diligence and the Company's satisfaction of the results, the two parties will enter into a definitive assets purchase agreement within five days. The definitive assets purchase agreement's execution shall be no later than December 31.

08:32 EDT Poet Technologies ships first optical engines samples to customers - POET Technologies reported that the Company has shipped its first 100G Transmit Optical Engine sample to a leading European optical systems company. The Company also confirmed that additional samples will be delivered to several other interested companies over the next month. Several prospective customers are expected to participate in POET's demonstrations of its Optical Interposer-based optical engine solutions this week, concurrent with the CIOE conference in Shenzhen. The sample delivered to a leading European optical systems company supports a combined transmit and receive Optical Engine product, which has been developed for an innovative 400G transceiver application. The Alpha samples demonstrate excellent margin to the transmit link budget at operating temperatures with excellent optical eye margins. Internal testing shows that only minor improvements are required for a Beta release that would meet all of the requirements for production. These changes have already been incorporated in the Beta designs, which have just been released to the mask shop for production.

08:30 EDT Rafael Holdings appoints Patrick Fabbio as CFO - Rafael Holdings announced the appointment of Patrick Fabbio as CFO. Pat Fabbio has more than 25 years of financial, operational and transactional leadership experience in both publicly-traded and privately-held life science and pharmaceutical companies. Prior to joining Rafael Holdings, Pat was CFO of WindMIL Therapeutics. Previously he served as the CFO of Progenics Pharmaceuticals, electroCore Medical; Vice President of Finance at NPS Pharmaceuticals. His other prior financial positions include roles at Sanofi, UniPath Diagnostics, BioMatrix and Coopers & Lybrand. Patrick is a board member of BeyondSpring Therapeutics.

08:29 EDT Wells Fargo CFO: Could see expenses $53B-$53.5B of FY21

08:26 EDT OmniMetrix partners with Power Solutions Specialist - OmniMetrix announced it has partnered with Power Solutions Specialist to provide remote monitoring and control equipment and services for thousands of Briggs and Stratton back-up power generators over the next twelve months. Based outside of Houston, Texas, PSS is a leading stand-by back-up power generator dealer and service provider in the region.

08:24 EDT Alignment Healthcare appoints Dan Peterson as president, Arizona - Alignment Healthcare announced the appointment of health care veteran Dan Peterson as president of its Arizona market. In this newly created position, Peterson will lead the company's expansion in the state and will report to Rajesh Shrestha, president, new markets and chief business officer at Alignment. Prior to joining Alignment, Peterson served as the CEO of Valor Health / Valor Hospice Care in Tucson.

08:22 EDT Emergent BioSolutions secures multi-year development agreement with Providence - Emergent BioSolutions and Providence Therapeutics announced they have entered into a five-year contract development and manufacturing, or CDMO, services agreement spanning Emergent's integrated capabilities, including development services, bulk drug substance formulation and drug product manufacturing, to support Providence's COVID-19 messenger RNA vaccine development. In 2022, Emergent will manufacture tens of millions of doses of PTX-COVID19-B drug product, as well as batches of PTX-COVID19-B formulated bulk drug substance with the potential to yield hundreds of millions more doses, for global populations in need of pandemic relief. Under the terms of the five-year agreement, Emergent will provide current Good Manufacturing Practice manufacturing services for two presentations of the PTX-COVID19-B vaccine product, both the formulated bulk drug substance and finished drug product, at Emergent's facility in Winnipeg, MB, Canada. Additional process and analytical development services will occur from Emergent's Center of Excellence for Development Services in Gaithersburg, Maryland. The baseline agreement signed between Emergent and Providence Therapeutics is valued at approximately $90M, covering manufacturing services, studies to support global supply chain activities, as well as facility and equipment investments.

08:20 EDT Aprea Therapeutics to present data from Phase 1/2 trial of eprenetapopt - Aprea Therapeutics announced an upcoming presentation of data for eprenetapopt in combination with pembrolizumab for the treatment of advanced solid tumors at the European Society of Medical Oncology Congress 2021 from September 16 - 21, 2021

08:19 EDT Twist continues to deliver synthetic RNA controls to fight Covid Delta+ variants - Twist Bioscience announced that it has started shipping its synthetic RNA reference controls for the SARS-CoV-2 AY.1 and AY.2, more commonly known as Delta Plus. Positive synthetic controls are robust reference tools used to confirm the accuracy of an assay and in the case of COVID, help classify and characterize virus samples. "We continue to update our synthetic controls for the latest variants of concern and variants of interest, monitoring the viral evolution to ensure we offer the tools to develop accurate tests in a timely manner," said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. "We now offer a total of 22 SARS-CoV-2 synthetic RNA controls in addition to 15 respiratory virus controls, to meet the needs of researchers globally."

08:18 EDT Sera Prognostics announces publication of health economic analysis on PreTRM - Sera Prognostics, The Pregnancy Company, announced the publication of a clinical and economic analysis using actual claims data from a broad population of Anthem affiliated health plans to assess the potential value of the PreTRM test-and-treat strategy. The study conservatively modeled the PreTRM strategy, consisting of testing and proactive evidence-based interventions, within Anthem claims data from individual and employer-sponsored plans, and showed both improved neonatal outcomes and reduced immediate and long-term treatment costs associated with premature birth, when compared to routine care. These results were published in the peer-reviewed journal ClinicoEconomics and Outcomes Research in an article entitled "Cost-Effectiveness of a Proteomic Test for Preterm Birth Prediction." The study analysis was conducted by Sera in partnership with HealthCore, using claims data of more than 40,000 pregnant women and infants who were members of individual and employer-sponsored Anthem health plans. The analysis evaluated the PreTRM test-and-treat strategy by modeling the application of the PreTRM test during weeks 19 or 20 of pregnancy, and assessed the benefit of proactive interventions consisting of more intensive case-management and monitoring, as well as pharmacologic interventions for women identified as higher-risk by the test, whereas usual care was assumed for any women without higher PreTRM risk. Based on the study's estimated net cost savings to the healthcare system of $863 saved per pregnant woman, the authors estimate that more than $850M could be saved annually in U.S. individual and employer-sponsored health plans, assuming full uptake of the test-and-treat strategy.

08:17 EDT Patriot One Technologies enhances MSG patron screening technology - Patriot One Technologies announced it has released the next phase of its threat detection multi-sensor gateway with technology enhancements that make it increasingly accurate, flexible and practical for sports and entertainment venues. MSG is a weapons detection scanner that stadiums and entertainment venues can deploy at points of entry. Unlike traditional metal detectors, the system uses sensors and purpose-designed artificial intelligence to scan for prohibited items such as guns and other weapons, accurately and unobtrusively at entry points. This eliminates the need for every patron to stop to empty their pockets and bags, which dramatically increases the rate at which people can enter facilities - improving the patron experience and maximizing revenue opportunities for venue operators, without compromising security. The new version of MSG includes additional sensing capabilities and AI features that further improve weapons-detection accuracy, including further improved detection for small weapons including knives, lower false alarm rates due to heavier clutter in pockets, and directional alerting. The new release also includes requested features to further optimize security personnel requirements, activities, and processes.

08:15 EDT Marquee Raine Acquisition, Enjoy adjust pro forma EV to $1.06B from $1.18B - Marquee Raine Acquisition Corp. (MRAC) and Enjoy Technology (ENJY) announced they have filed an updated investor presentation on Form 8-K with the SEC in connection with the previously announced business combination between Marquee Raine and Enjoy. The investor materials outline Enjoy's recent business developments and operating performance, including: Enjoy is launching a complete Smart Last Mile solution in North America in Q4 2021. This transformational change will enable Enjoy to access significantly more inventory and address a larger share of its partners' customer demand. Enjoy plans to serve all existing U.S. markets with this solution in time for the 2021 holiday season. In response to requests from its partners, Enjoy plans to expand to more than 45 new markets across North America by the end of 2022. With this substantial geographic expansion, Enjoy will serve a total of approximately 100 markets in North America and expand its global population coverage from 200 million to about 235 million addressable customers. Continued expansion with Apple during Summer 2021 triples Enjoy's reach with Apple to cover more than 67 million total addressable consumers in 14 markets. To meet these expansion needs, Enjoy is pulling forward $10 million of investment to increase certainty it can begin 2022 with more than 1,000 mobile stores. This investment gives Enjoy great confidence in its 2022 plan and path to achieve company-level profitability in 2023. Enjoy currently expects to achieve 2021 forecast revenue of $109 million. With a Q2 2021 revenue per visit exit rate of $77 globally, and $84 in North America, Enjoy continues to have confidence in achieving its 2021 and 2022 revenue per visit forecasts. Enjoy expects to achieve mobile store profitability in Q4 2021.Enjoy has secured commitments from current and key investors of up to $100 million at $10.00 per share, if necessary as a result of shareholder redemptions. Reflecting current market conditions, Enjoy and Marquee Raine have adjusted the combined company's approximate pro forma enterprise value from $1.18 billion to $1.06 billion. Marquee Raine and Enjoy expect the business combination to be completed [early] in the fourth quarter of 2021. Upon completion of the transaction, the combined company will operate as Enjoy Technology Inc., and its common stock and warrants will be listed on the Nasdaq stock exchange under the new ticker symbols "ENJY" and "ENJYW," respectively.

08:14 EDT Teledyne launches Teledyne Geospatial group - Teledyne announces the launch of a geospatial group with the unification of its Optech and CARIS businesses. The new Teledyne Geospatial group will offer holistic solutions to seamlessly map land and sea through the integration of industry-leading lidar sensors combined with world-renowned software workflows. Teledyne Optech has been a world leader in the design, development and manufacture of advanced lidar instruments for more than 45 years. And for over four decades, Teledyne CARIS has developed market-dominating software for the marine GIS community. This collaboration provides customers with a competitive edge in mapping and delivering data products inside of one complete workflow. Ease of collection and processing, through to final product, is enhanced with efficiency-driving AI algorithms and real time quality control. Ongoing collaborations with other Teledyne businesses extends the geospatial capabilities even further. The CZMIL SuperNova, the first product from Teledyne Geospatial, integrates Optech's bathymetric lidar with CARIS' comprehensive processing software providing the highest performing bathymetric lidar system in the world.

08:13 EDT Medicenna Therapeutics doses first patient in MDNA11 Phase 1/2 ABILITY study - Medicenna Therapeutics announced the initiation of dosing of patients in the Phase 1/2 ABILITY study of MDNA11, the Company's selective, long-acting and novel IL-2 super-agonist. The study is designed to assess the safety, PK, PD, and anti-tumor activity of various doses of intravenously administered MDNA11 in patients with advanced solid tumors and includes an MDNA11 monotherapy arm, as well as a combination arm designed to evaluate MDNA11 with a checkpoint inhibitor. The ABILITY study is currently enrolling patients at clinical trial sites in Australia with expansion to additional sites planned in the United States, Canada, and the United Kingdom. Medicenna expects the remaining regulatory submissions for these jurisdictions to be completed this calendar year. The ABILITY study plans to enroll at least 80 patients with advanced, relapsed, or refractory solid tumors. Patients will receive MDNA11 via intravenous administration in an out-patient setting. Following establishment of the recommended dose and treatment schedule, Medicenna plans to enroll expansion cohorts of patients with renal cell carcinoma and melanoma along with a cohort of patients with other solid tumors in monotherapy and combination settings. A preliminary update on safety, PK/PD, and biomarker data from early cohorts of patients enrolled in the dose escalation phase of the ABILITY Study this year is expected by the end of calendar 2021. Preliminary efficacy updates from the study are expected at various times during calendar 2022.

08:11 EDT Atlas Air, DHL Express extend agreements for 20 freighters - Atlas Air announced it has entered into contract extensions with DHL Express to continue operating 20 freighter aircraft in support of their fast-growing express and e-commerce markets. These agreements build on the long-standing strategic partnership between Atlas Air Worldwide and DHL, which began in 2008 and included DHL acquiring 49% of AAWW's subsidiary, Polar Air Cargo, as well as a long-term agreement for six dedicated 747-400Fs to operate on key Trans-Pacific routes. The partnership has grown significantly over the years, and under these extended agreements, Atlas Air will continue to operate four different aircraft platforms for DHL Express, including: Six Boeing 747-8 freighters; Two Boeing 747-400 freighters; Eight Boeing 777-200 freighters; Four Boeing 767-300 freighters.

08:08 EDT Analog Devices appoints Janene Asgeirsson as Chief Legal Officer - Analog Devices has appointed Janene Asgeirsson as the company's new Senior Vice President, Chief Legal Officer and Corporate Secretary. Asgeirsson is a highly accomplished legal advisor with more than 20 years of experience in corporate law. She will be responsible for overseeing ADI's legal matters, including M&A, litigation, intellectual property, governance, compliance and corporate matters. She is also responsible for the company's internal audit and risk functions in her capacity as Chief Risk Officer.

08:08 EDT WM Technology acquires Sprout CRM and marketing platform - WM Technology announced that it has acquired Sprout, a cloud-based CRM and marketing platform for the cannabis industry. WM Technology's acquisition of Sprout reinforces the company's end-to-end operating system.

08:07 EDT Quotient and Figg team to bring new product savings to 100M+ shoppers - Quotient announced its digital, product-level promotions will now be available to more than 100M+ enrolled cardholders through a new partnership with Figg. Figg is a leading transaction-based digital advertising platform company for financial institutions, banks, fintechs and digital platforms in the United States. SKU-level rebates available on Quotient's national network will now be available for cardholders across Figg's bank and publisher network. This new partnership with Figg enables enrolled cardholders to access grocery offers from Quotient's 2,000+ brand partners, including Clorox, General Mills, and Unilever, complementing Figg's existing restaurant, retail and entertainment offer portfolio. Quotient's innovative promotions platform enables Figg to provide more value to cardholders with product-specific offers. Shoppers simply use an enrolled card and experience seamless personalized savings-rebates selected will be digitally matched with the shoppers' credit and debit card purchases-with no additional steps. Consumer packaged goods, CPG, brands will see increased promotional reach through this partnership, and retailers will benefit as promotions that are already on their websites will now also be available to Figg's 100M+ enrolled cardholders. "This integration enables us to provide savings to a larger audience in a new space. We are excited to expand reach for our brand and retail customers, and continue to offer more innovative, personalized and sophisticated alternatives to promotional tactics like printed free-standing inserts," said Steven Boal, CEO and Founder at Quotient. "Figg is a great partner for us to provide grocery rebates to financial institution cardholders, creating easier access for consumers to find savings in their shopping journey and giving them more value from everyday purchases."

08:06 EDT FuboTV selects Magnite as preferred SSP - Magnite (MGNI) announced that fuboTV (FUBO), the leading sports-first live TV streaming platform, has selected Magnite to serve as its preferred sell-side platform.

08:05 EDT NV5 Global selected by US Geological Survey for contract valued up to $850M - NV5 Global announced that the US Geological Survey, or USGS, has selected NV5 for a multiple-award indefinite delivery contract with a ceiling of $850M for Geospatial Product and Services Contract, or GPSC4. Services provided under the GPSC4 contract support federal, state, and municipal government entities that partner with the USGS for their geospatial data requirements. GPSC4 supports multiple federal and state programs including the 3D Elevation Program, FEMA Flood Mapping, 3D National Hydrography Program, and Earth Mapping Resources Initiative. Under the contract, NV5 will provide advanced geospatial data acquisition, processing, and analytics utilizing leading-edge technologies such as topographic lidar, riverine and coastal topo-bathymetric lidar, multispectral imagery, geophysical surveying, and elevation-derived hydrography. "Since 1997, NV5 Geospatial has supported the USGS as the nation's leading resource for geospatial data by delivering the latest geospatial technologies and data analytics to the USGS and its partners," said Dickerson Wright, PE, Chairman and CEO of NV5. "Services provided under the GPSC4 contract will support water quality and conservation, floodplain and coastal management, sea level rise, natural resource conservation, infrastructure management, aviation safety, and renewable energy." The GPSC4 contract has a maximum duration of five years and is the successor to GPSC3. NV5 was awarded $135M in revenue on the GPSC3 contract over a period of five years. GPSC contracts are AE qualifications-based awards, and NV5 has held consecutive contracts for over 20 years.

08:04 EDT iSpecimen to be included in Russell Microcap Index at open on 9/20 - iSpecimen announced that it will be included in the Russell Microcap Index, effective after the U.S. market opens on September 20, as part of the 2021 Russell indexes reconstitution.

08:03 EDT NeuBase Therapeutics appoints Rossomando as Chief Technology Officer - NeuBase Therapeutics announced the appointment of Anthony Rossomando, Ph.D., as Chief Technology Officer. Rossomando has more than 25 years of experience as a biopharmaceutical drug developer who has led teams from start-up to global biotechnology companies that have established the upstream and downstream process development of biologics and peptide molecules. At NeuBase, Rossomando will be responsible for manufacturing and process development, analytical development, and biophysical characterization in support of FDA regulatory submissions. Prior to joining NeuBase, Rossomando was Chief Process Development Officer at Pinetree Therapeutics.

08:02 EDT Chris Marlin steps down as President of Lennar International - Chris Marlin has stepped down as President of Lennar International after eight years in the role. Marlin founded Lennar International as the foreign home sales and marketing arm of Lennar Corporation and a leader in global capital sourcing. Marlin will remain involved in real estate investment, focusing on foresight and risk strategies with an emphasis on ClimateTech and PropTech. He recently was named a strategic advisor and member of the Board of Directors of Singapore-based ClimateAlpha.ai, an AI-driven software and advisory firm that leverages machine learning to produce price and other forecasts for real estate assets, including climate impacts. Marlin also will advise Vesta Ventures, a residential sector early-stage investment fund.

07:51 EDT Cboe FX Markets launches algorithmic service in collaboration with XTX Markets - Cboe FX Markets, a Cboe Global Markets company, announced the launch of a hosted algorithmic execution service in collaboration with leading electronic liquidity provider XTX Markets. This service will help enable Cboe FX participants to access the XTX Markets Execution Algo, which is designed to alleviate implementation shortfall, via the Cboe FX ECN. Cboe FX has been granted exclusive rights over use of the XTX Algo in the anonymous ECN space and this service is available for execution of the most actively traded pairs in the spot FX market. Cboe FX participants can access the XTX Algo on an anonymous or disclosed basis via the Cboe FX ECN using their existing Cboe FX technology and legal arrangements.

07:46 EDT Jacobs awarded $320M contract by the National Geospatial-Intelligence Agency - Jacobs was awarded a contract by the National Geospatial-Intelligence Agency, or NGA, to provide mission-driven and data-centric solutions in support of Geospatial-intelligence Enterprise OpenDataStore, or GEODS, services. The single-award indefinite delivery/indefinite quantity, or IDIQ, contract value is estimated at $302M across a seven-year ordering period.

07:42 EDT CloudMD partners with 19 post-secondary institutions for mental health programs - CloudMD Software & Services announced that it has partnered with 19 new post-secondary institutions across Canada to provide its Aspiria Student Assistance Program and multi-layered mental health resources to over 167,000 additional students. With growing mental health concerns surrounding the pandemic and students returning back to school, CloudMD is onboarding the network of colleges and universities of various sizes ranging from 200 students to 48,000 students to provide additional resources to support the increased demand for mental health programs for younger individuals.

07:40 EDT FirstService announces subsidiary acquired Insurance Restoration Specialists - FirstService Corporation announced that its subsidiary, First Onsite Property Restoration, has recently acquired Insurance Restoration Specialists. Terms of the transaction were not disclosed. "This transaction follows on the heels of our prior acquisition of Manhattan-based Maxons Restorations. The addition of IRS provides us with greater capabilities to serve the marquee New York City market and the broader Tri-State region of New York, New Jersey and Connecticut," said Stacy Mazur, First Onsite CEO, U.S. "The strong, collaborative leadership at IRS, combined with their deep customer relationships and environmental experience in key practice areas, provides a seamless fit with our operations. We look forward to having them join the First Onsite team," he concluded.

07:39 EDT Probe Metals names Ann Lamontagne director, environment, sustainability - Probe Metals announced the appointment of Ms. Ann Lamontagne as the director of infrastructure, environment and sustainability. Lamontagne is a civil engineer with a PhD in Mining Environment from the department of Mines & Metallurgy Engineering at Laval University. She has worked for several mining consulting firms, including SNC-Lavalin and Golder, and founded her own company, Lamont Inc. in 2010. As a consultant she was involved in a broad spectrum of mining projects, predominantly as a project manager for geotechnical and environmental programs. Since 2007, she has been increasingly involved in the permitting processes for mining projects, interacting with proponents, legislators, governmental officials, legal, and stakeholders.

07:39 EDT CureVac streamlines European network for mRNA product manufacturing - CureVac announced its strategic decision to adjust the long-term footprint of the external European manufacturing network for its mRNA product pipeline. The decision was made in response to the reduced short-term peak demand for vaccines following the first wave of the pandemic vaccination efforts and corresponding changes in the demand of its first-generation COVID-19 vaccine candidate, CVnCoV, currently under regulatory review with the European Medicines Agency, EMA. As a result, the existing contracts with WACKER for the manufacturing of the mRNA drug substance of CVnCoV and Celonic for the manufacturing and formulation of the mRNA drug substance of CVnCoV will be terminated. CureVac's existing agreements with Rentschler Biopharma and Novartis for mRNA production and formulation are unaffected by this adjustment and remain in place. Streamlining of capacity does not limit availability of clinical trial material for CV2CoV, the second-generation COVID-19 vaccine candidate jointly developed with GSK, expected to enter the clinic in the fourth quarter of 2021. "The continuous increase in mRNA manufacturing capacity together with the progress of large-scale vaccination efforts have strongly changed the demand for our first-generation COVID-19 vaccine, CVnCoV, over the last months," said Dr. Malte Greune, Chief Operating Officer of CureVac. "The development from a very high, short-term pandemic demand to broader availability of vaccines has led us to re-evaluate our immediate manufacturing capacity requirements in order to align the capacity with actual commercial and clinical capacity needs for CVnCoV. We would like to thank both our manufacturing partners for their dedication and effort in achieving our common goal to combat the pandemic with this key technology."

07:38 EDT Masonite announces pricing of secondary public offering - Opendoor Technologies announced the pricing of its previously announced registered secondary public offering of 28,000,000 shares of common stock by an existing stockholder of Opendoor. The Selling Stockholder has also granted the underwriter a 30-day option to purchase up to an additional 4,200,000 shares of common stock from the Selling Stockholder. Opendoor is not selling any shares and will not receive any proceeds from the offering, which is expected to close on September 16, 2021, subject to customary closing conditions.

07:37 EDT Boeing sees demand for over 2.1M aviation personnel over next 20 years - As the commercial aviation industry continues to make progress toward recovery from the pandemic, a steady increasing supply of personnel and effective training remain critical to retain the health, safety and prosperity of the aviation ecosystem. Long-term demand for newly qualified aviation personnel remains strong, with projected demand for more than 2.1M personnel needed to fly and maintain the global commercial fleet over the next 20 years, including 612,000 pilots, 626,000 maintenance technicians and 886,000 cabin crew members.

07:36 EDT AES acquires 49.9% stake in AES Colon from Inversiones Bahia - The AES announced the acquisition of a 49.9% stake in AES Colon from Inversiones Bahia, increasing its ownership to 100% of AES Colon. AES Colon is comprised of a 381 MW liquid natural gas, or LNG,-fired power plant and an 180,000 cubic meter LNG storage and regasification facility. The project came on-line in 2018 and 100% of the output from the generation facility is contracted through 2028.

07:35 EDT Boeing sees $2.6T defense and space market opportunity through 2030 - The BMO also projects the defense and space market opportunity will remain consistent with last year's forecast at $2.6T during the next decade. These large, stable markets have enduring demand driven by geopolitical and security challenges. This spending projection continues to reflect the ongoing importance of military aircraft, autonomous systems, satellites, spacecraft and other products for national and international defense, with 40 percent of expenditures expected to originate outside of the United States. "While we've seen resiliency and stability in the global defense and space market, the threat environment continues to evolve," said Leanne Caret, president and CEO of Boeing Defense, Space & Security. "Winning the future fight will require speed and flexibility, and Boeing is committed to designing, testing, building and sustaining in a way that will enable our customers to adapt at the speed of relevance and derive the most value from our platforms for decades to come. Our mission - which is grounded in safety, quality and integrity - is to deliver the most digitally advanced, simply and efficiently produced solutions that are intelligently supported to our global customers."

07:34 EDT Apollo Global, Alain de Krassny enter negotiations for sale of Kem One Group - Alain de Krassny and Apollo Global Management declare that they have entered into exclusive negotiations for the sale of the Kem One Group to funds managed by affiliates of Apollo. These discussions are taking place through De Krassny GmbH and the Apollo Funds. This proposed sale, for which the two parties signed a put option agreement, as is typical in French M&A transactions, on September 10th, is expected to be finalized by the end of the year. With 1,400 employees and 8 industrial sites located across France and Spain, Kem One is a leading European producer of polyvinyl chloride, used mainly in construction, packaging, and medical applications, and caustic soda. Kem One has leading positions in both mass and suspension PVC in Europe, and recognized expertise in specialty PVC, including paste PVC and post-chlorinated PVC. Under Mr. de Krassny's leadership, Kem One has undergone a complete transformation since 2014, executing on a long-term strategy to improve the quality and reliability of its production facilities, lower production costs, and reduce its environmental footprint. The strategy was anchored by an ambitious investment program of more than EUR 500 million, with three strategic projects: The conversion and upgrade of the electrolysis units of Kem One's Lavera plant, completed in 2017; The construction of an ethylene storage terminal at Kem One's Fos-sur-Mer plant, to be finalized in Q4 2021; The conversion and upgrade of the electrolysis units at Fos-sur-Mer which will be launched in the coming months and would be completed under Apollo's ownership. The financial terms of the transaction were not disclosed. The transaction is subject to the customary approval of the competition and regulatory authorities and to the information and consultation process of the bodies representing the personnel concerned.

07:32 EDT Accuray announces data from its PACE trial using CyberKnife platform - Accuray announced that data from the PACE, or Prostate Advances in Comparative Evidence, trial indicate the company's CyberKnife robotic radiotherapy platform is superior to conventional linear accelerators in reducing the incidence of late grade two or higher bladder toxicity associated with prostate cancer stereotactic body radiation therapy, or SBRT treatments. The two-year follow-up data presented at the European Society for Radiotherapy and Oncology annual congress showed that bladder side effects were experienced half as often with CyberKnife SBRT as with conventional linear accelerator delivered SBRT. Long-term side effects can affect patients for the rest of their lives. Technology that can minimize the risk of these side effects is critical. The PACE data are important because they suggest that men treated with CyberKnife SBRT are less likely to experience long-term side effects that can impact them over the course of their lives compared with men receiving conventional linear accelerator delivered SBRT.

07:32 EDT Mindset says MSP-1014 comparable to psilocybin assessed using assay - Mindset Pharma announced that its lead candidate, MSP-1014, was comparable to psilocybin assessed using a drug discrimination assay. The results suggest that MSP-1014 induces a similar perceptual state to psilocybin, further confirming the viability of MSP-1014 as a therapeutic analog of first-generation psilocybin as the Company advances MSP-1014 into the clinic.

07:23 EDT Futu Holdings announces resignation of director Eric Chi Zhang - Futu Holdings announced that Mr. Eric Chi Zhang, a director of the Company, has resigned from the board of directors of the Company due to personal reasons, effective September 14, 2021. Mr. Zhang's resignation did not result from any disagreement with the Company.

07:19 EDT HP Inc., Embark Trucks announce joint distribution network initiative - Embark Trucks announced a joint initiative with HP Inc. to combine electric and autonomous truck technology and create a more sustainable distribution network. The two companies launched an electric truck drayage pilot in the Los Angeles area, where local loads are hauled to and from Embark's highway-adjacent transfer points using BYD 8TT electric trucks operated by human drivers, while the longer middle segment of the haul is completed autonomously by trucks equipped with the Embark Driver software. This EV drayage pilot gives HP the ability to leverage electric trucks within its supply chain. Adopting both long-haul autonomous trucks and EV drayage enables HP to remove up to 50,000 tons of carbon dioxide and other pollutants from its distribution network over the next ten years, according to preliminary research by Embark.

07:18 EDT Osisko Mining reports results from expanding Golden Bear discovery - Osisko Mining is pleased to provide new results from the expanding Golden Bear discovery located approximately 1000 metres north of its 100% owned high-grade Windfall gold deposit, located in the Abitibi greenstone belt, Urban township, Eeyou Istchee James Bay, Quebec. Additional reconnaissance drilling has confirmed the Golden Bear discovery zone and has also identified two new mineralized zones. Drilling 50 metres south-east from D1 has defined the presence of parallel gold zone D2. Drilling 200 metres south-east of D1 has defined the presence of a third parallel zone of alteration hosting significant sulfide mineralization. All three zones display alteration, sulfide mineralization and local visible gold, and all three remain open both up and down plunge and along strike. Golden Bear displays similar orientation features observed at Windfall where the principal mineralized areas, including Lynx, can occur as clusters of high-grade zones which extend laterally for over a kilometre. Three drills have now been assigned to Golden Bear to explore along strike and up and down plunge, with more planned to join as the infill program at Windfall reaches completion. D1 has currently been traced 170 metres along strike with a plunge to the east-northeast. Drill hole OSK-UB-21-273 returned 67.10 g/t Au over 2.0 metres 60 metres up-plunge from the discovery intercept. Drill holes OSK-UB-21-264 and OSK-UB-21-272 returned 14.90 g/t Au over 2.0 metres and 26.53 g/t Au over 2.2 metres, respectively, 50 metres and 70 metres down-plunge from the discovery intercept. D2 is a sub-parallel mineralized trend 50 metres south-east from D1, which returned 62.15 g/t Au over 2.0 metres in hole OSK-UB-21-261. D3 is located 200 metres south-east of D1, open in all directions, and is currently defined by one intercept: 38.67 g/t Au over 2.2 metres in drillhole OSK-UB-21-276; and pending assay results in OSK-UB-21-278, a 250-metre step-out hole to the east of OSK-UB-21-276. The D1 discovery hole returned 27.40 g/t Au over 6.7 metres in OSK-UB-21-232. Golden Bear is a "blind" discovery in a geological setting with many similarities to Windfall. Windfall has an extensive alteration and mineralization footprint of over 4km strike length and approximately 3km vertical extent. The scale of Windfall indicates a significant mineralizing event in the Urban Barry belt. Many of the district intrusives hosting gold mineralization bear similar emplacement age dates, suggesting a district-scale mineralizing event was responsible for the Windfall deposit. Golden Bear is another example of this district-scale mineralization, and there is good potential that additional deposits remain to be discovered. Osisko's extensive land package dominates the district and the principal mineralized structures in the Urban Barry gold camp. A drill program of 50,000 metres, funded with cash on hand, is in progress to explore Golden Bear and the immediate surrounding areas.

07:15 EDT DermTech TRUST study of DermTech Melanoma Test reduces biopsy burden - DermTech announced that SKIN: The Journal Of Cutaneous Medicine has published research including the results of DermTech's TRUST study. The large research study supports that evaluation of genomic atypia with DermTech's Pigmented Lesion Assay , PLA or the "DermTech Melanoma Test, increases both the real-world negative predictive value, NPV and positive predictive value, PPV, of the melanoma diagnostic pathway and reduces biopsy burden, relative to the current visual assessment and histopathology pathway. The publication, "Non-Invasive Detection of Genomic Atypia Increases Real-World NPV and PPV of the Melanoma Diagnostic Pathway and Reduces Biopsy Burden," reports that the non-invasive detection of genomic atypia by the PLA can complement visual assessment of pigmented lesions and enhance the early detection of melanoma, enabling clinicians to triage suspicious lesions more effectively to determine which lesions are high risk and should be biopsied versus safely managing benign lesions via clinical surveillance. The TRUST study was conducted in the U.S. by examining a cohort of 2,575 PLA-tested lesions for evidence of melanoma detected during a protracted follow-up period of up to 36 months and by re-testing a subset of 302 PLA-negative lesions up to 24 months after the initial PLA test. These results demonstrate that in this real-world intended use population, the PLA has an NPV of greater than 99%, confirming the high NPV established in previous clinical studies.

07:13 EDT Green Thumb Industries to open Rise Bloomfield in New Jersey - Green Thumb Industries announced it will open Rise Bloomfield, the Company's third store in New Jersey and 65th in the nation. Profits from the first day of sales will be donated to the Bloomfield Youth Aid Foundation, a non-profit organization dedicated to providing services to Bloomfield youth, including scholarship funds, toy drives and summer youth programs.

07:12 EDT Spire Global to acquire exactEarth for $161.2M in cash, stock - Spire Global and exactEarth announced that the companies have entered into a definitive arrangement agreement under which Spire will acquire exactEarth for approximately $161.2M in cash and stock, which implies ~9.1x exactEarth's Enterprise Value to LTM revenue. Once completed, exactEarth will become a fully owned subsidiary of Spire and continue to operate from Cambridge, Ontario, Canada under the leadership of exactEarth's CEO Peter Mabson, reporting directly to Spire CEO Peter Platzer. The combined company aims to be transformative for customers and the maritime industry. Bringing together real-time and historical space-based maritime data, Spire and exactEarth will provide customers with innovative solutions that drive the digitalization of the almost US$2 trillion global maritime industry, such as better fleet visibility for more efficient routing, cost savings from reduced fuel consumption, and a lower environmental footprint. Strategic Rationale Increases Spire's customer base by over 75%. In the maritime S-AIS industry, exactEarth will accelerate Spire's expansion by adding over 150 customers. These customers in the commercial and government sectors will provide substantial cross-selling opportunities of Spire's data and analytics products. Minority indirect ownership stake in IoT provider Myriota, a fast growing player in the low-cost, low-power, secure direct-to-orbit satellite connectivity for Internet of Things. This affords Spire a solid first foothold in this high-growth industry of space-based IoT solutions. exactEarth will retain its board seat. Strong Addition to ARR. With approximately 90% of exactEarth's $18.2 million LTM revenue under subscription contracts, and a Net Retention Rate of approximately 130%, exactEarth will accelerate Spire's growth in annual recurring revenue. Expands Historical Database to accelerate AI/ML driven product development. exactEarth's 10-year archive of AIS data will substantially increase Spire's historical maritime data set, accelerating Spire's new product offerings and solutions. Adds depth of experience to maritime and product development teams. With an average tenure of over 7 years, exactEarth's experienced sales and product development team will enhance Spire's global market capability and reach in the maritime industry. Expands Spire's geographic footprint. exactEarth sells to 39 countries around the world. Details on the Proposed Transaction The total transaction consideration of C$204.2m is comprised of approximately C$130.9M in cash and C$73.2 million in Spire's Class A Common Stock. The transaction will be carried out through a plan of arrangement under the Canada Business Corporations Act. Under the plan of arrangement, holders of exactEarth common shares will receive C$2.5009 in cash and 0.1 share of Spire Class A Common Stock for each exactEarth common share held. Based on the 10-day volume weighted average price of Spire's Class A Common Stock on the New York Stock Exchange of US$11.0223 on Monday September 13, 2021, this represents total per share consideration of C$3.90 per common share for exactEarth shareholders. On completion of the arrangement, the former shareholders of exactEarth will hold approximately 3.8% of Spire, based on currently outstanding share capital. The transaction is expected to be accretive on both a revenue basis and an adjusted EBITDA basis. The transaction has been approved by the boards of directors of both companies and exactEarth's board of directors recommends that exactEarth shareholders vote in favor of the transaction. The completion of the transaction is subject to approval by at least two-thirds of the votes cast at a special meeting of exactEarth shareholders which is expected to take place in November 2021.The transaction is also subject to applicable regulatory approvals and the satisfaction of certain closing conditions customary in transactions of this nature. The transaction is not subject to any financing condition.The directors, officers and certain shareholders of exactEarth, collectively holding approximately 60% of its outstanding common shares, have entered into voting support agreements under which they have agreed to support and vote in favor of the transaction. This acquisition is expected to close in calendar 4Q21 or in calendar 1Q22.

07:11 EDT Novocure, Roche team to evaluate TTFields for metastatic pancreatic cancer - Novocure (NVCR) announced it has entered into a clinical trial collaboration agreement with Roche (RHHBY), to develop Tumor Treating Fields, TTFields, together with Roche's anti-PD-L1 therapy, atezolizumab, in metastatic pancreatic ductal adenocarcinoma, mPDAC. Pancreatic ductal adenocarcinoma, PDAC, is the most common type of pancreatic cancer and accounts for 85%-95% of all solid pancreatic tumors. As a highly lethal malignancy, it is the seventh leading cause of cancer death worldwide and is responsible for more than 300,000 deaths per year. PDAC is highly resistant to current therapies, affording patients a 5-year overall survival rate of only 7.2%. "We are pleased to collaborate with Roche, a global leader in oncology, to explore the efficacy of TTFields together with atezolizumab immunotherapy in pancreatic cancer," said William Doyle, Novocure's Executive Chairman. "The immune-shielded environment of the pancreas has proved challenging for immunotherapies alone to provide benefit. Our phase 2 pilot trial with Roche will study the ability of TTFields together with atezolizumab to improve clinical outcomes for patients with this deadly disease." The phase 2 study was designed to test the safety and efficacy of TTFields together with atezolizumab, gemcitabine and nab-paclitaxel as a first-line treatment for mPDAC. The study is designed to enroll approximately 75 patients in the EU and United States. The primary endpoint of the study is disease control rate by RECIST 1.1. The secondary endpoints include overall survival, progression free survival, one year survival, objective response rate, PFS at six months, duration of response, and toxicity profile. Novocure is the study sponsor and Roche is providing atezolizumab for the trial.

07:10 EDT Helius Medical appoints Paul Buckman to board of directors - Helius Medical Technologies (HSDT) announced the appointment of Paul Buckman to its Board of Directors, effective September 10, 2021. Buckman will serve as Chair of the company's Audit Committee and as a member of its Compensation and Nominating & Governance Committees. Buckman is currently the President, North America for LivaNova (LIVN), a global medical technology company that designs, develops, manufactures and sells innovative therapeutic solutions in the fields of neuromodulation and cardiovascular disease, a position he has held since 2017. In addition, he currently serves on the Board of Directors of several public and private medical device companies.

07:09 EDT DoubleDown launches Undead World: Hero Survival - DoubleDown Interactive announced the launch of Undead World: Hero Survival, a zombie apocalypse RPG that uses a mixture of idle gameplay and character collecting and upgrading. This launch marks a strategic departure for the company, which has previously focused on the casino genre. Undead World: Hero Survival is expected to launch worldwide in late September and will be available on iOS and Android devices.

07:08 EDT Spire Global to acquire exactEarth for $161.2M in cash, stock - Spire Global and exactEarth announced that the companies have entered into a definitive arrangement agreement under which Spire will acquire exactEarth for approximately $161.2M in cash and stock, which implies 9.1x exactEarth's enterprise value to LTM revenue. Once completed, exactEarth will become a fully owned subsidiary of Spire and continue to operate from Cambridge, Ontario, Canada under the leadership of exactEarth's CEO Peter Mabson, reporting directly to Spire CEO Peter Platzer. With approximately 90% of exactEarth's $18.2M LTM revenue under subscription contracts, and a net retention rate of approximately 130%, exactEarth will accelerate Spire's growth in annual recurring revenue, or ARR. The total transaction consideration of $161.2M is comprised of approximately $103.4M in cash and $57.8M in Spire's Class A common stock. The transaction will be carried out through a plan of arrangement under the Canada Business Corporations Act. Under the plan of arrangement, holders of exactEarth common shares will receive $1.98 in cash and 0.1 share of Spire Class A Common Stock for each exactEarth common share held. Based on the 10-day volume weighted average price of Spire's Class A Common Stock on the New York Stock Exchange of $11.02 on September 13, this represents total per share consideration of $3.08 per common share for exactEarth shareholders. On completion of the arrangement, the former shareholders of exactEarth will hold approximately 3.8% of Spire, based on currently outstanding share capital. The transaction is expected to be accretive on both a revenue basis and an adjusted EBITDA basis. The transaction has been approved by the boards of directors of both companies and exactEarth's board of directors recommends that exactEarth shareholders vote in favor of the transaction. The completion of the transaction is subject to approval by at least two-thirds of the votes cast at a special meeting of exactEarth shareholders which is expected to take place in November. The transaction is also subject to applicable regulatory approvals and the satisfaction of certain closing conditions customary in transactions of this nature. The transaction is not subject to any financing condition. The directors, officers and certain shareholders of exactEarth, collectively holding approximately 60% of its outstanding common shares, have entered into voting support agreements under which they have agreed to support and vote in favor of the transaction. This acquisition is expected to close in calendar Q4 or in Q1.

07:07 EDT LHC Group to purchase two providers in Virginia - LHC Group announced agreements to purchase two providers in Virginia, complementing and expanding on its existing footprint of providers in the state. The in-home healthcare company will purchase Generations Home Health, and Freda H. Gordon Hospice and Palliative Care, both in Virginia Beach. The agencies will continue operating under their current names. The acquisitions are expected to close on October 1, subject to customary closing conditions. LHC Group expects annualized revenue from these purchases of approximately $7M and that it will not materially affect its 2021 diluted earnings per share.The company also finalized an expansion of its JV in Arkansas with Baptist Memorial Health Care, adding Elite Home Health in Jonesboro to the partnership's portfolio. The home health agency, which was already part of the LHC Group family, will align with NEA Baptist Memorial Hospital.

07:07 EDT ADM,LG Chem sign MoU for U.S.production of lactic acid for plant-based product - LG Chem and ADM announced that they have signed a memorandum of understanding, MoU, to explore US-based production of lactic acid to meet growing demand for a wide variety of plant-based products, including bioplastics. Under the terms of the agreement, which was signed by ADM Chairman and CEO Juan Luciano and LG Chem Vice Chairman and CEO Hak Cheol Shin at ADM's global headquarters in Chicago, the two companies plan to take steps toward launching a joint venture in early 2022 that would build, own and operate a US-based facility to produce high-purity corn-based lactic acid on a commercial scale. According to Grand View Research, global demand for lactic acid - which is used broadly in food, feed and cosmetics in addition to industrials like bioplastics - was valued at approximately USD 2.7 billion in 2020, with an expected annual growth rate of 8%. In addition, the companies will collaborate on a second joint venture that would use lactic acid produced by the first joint venture to produce and commercialize polylactic acid , PLA, a plant-based, biodegradable plastic that can be used in a wide array of products, from food packaging to clothing to upholstery. According to new market research by MarketsandMarkets, demand for global bioplastics and biopolymers is projected to grow from USD 10.7B in 2021 to USD 29.7B by 2026, representing a CAGR of 22.7%. The two companies also agreed to actively cooperate in the joint development of technology for other biomaterials that can be applied in the biochemical and sustainability sector in the future.

07:05 EDT Standard Lithium initiates Arkansas Carbon Capture Project - Standard Lithium announced that it is undertaking a pilot project in southern Arkansas to test a novel carbon capture technology. The pilot project will be undertaken in collaboration with the owner of the technology, Aqualung Carbon Capture, and will be installed at a natural gas processing site in southern Arkansas owned and operated by Mission Creek Resources. Standard Lithium's ongoing operations lead the industry in advancing sustainability and circular economy. By funding this project, Standard seeks to build on its science-based strategy for sustainable development and continuous improvement at its Arkansas lithium projects. The Company is focused on minimizing all CO2 emissions that may result from its future operations and related supply-chain activities. The Company has identified several areas where CO2-rich gas streams may be used to optimize its process and reduce reagent costs, as well as potentially sequester CO2. Standard Lithium's current and planned expansion of its production of a key battery metal advances the U.S. goal to "secure an end-to-end domestic supply chain for advanced batteries", as well as support the "sustainable domestic production and processing of critical minerals." Today's announced pilot project builds on and aligns with the White House's Carbon Capture, Utilization and Sequestration announcement on June 30, 2021, which seeks to develop and deploy CCUS technologies to improve industrial processes. Aqualung, a Norwegian technology company, is the sole license owner of the patent-protected technology, which was developed by the Norwegian University of Science and Technology, and results from over 20 years of research at NTNU into membrane separation of gasses. The technology is based on a membrane system that selectively extracts CO2 from a wide range of CO2 sources emitted by hydrocarbon-burning energy sources. It produces a high purity CO2 gas stream that can either be sequestered or reused. The technology has been successfully piloted in Europe, where it has been shown to effectively extract CO2 from carbon gas streams. The pilot project will be located at Mission Creek's Dorcheat Macedonia facility and will take a slipstream of flue gas for processing through the Aqualung pilot unit. The resulting concentrated CO2 stream will be utilized in Standard Lithium's ongoing R&D activities to investigate the utilization of southern Arkansas sourced CO2 for process and reagent optimization. Manufacturing of the pilot unit is expected to begin in Q4 2021, and, pending permitting and finalizing of other agreements, to be installed at the project site in Q1/2 2022.

07:03 EDT Halliburton awarded integrated services contract from Energean - Halliburton announced it was awarded an integrated services contract to execute a three to five well drilling and completions campaign for Energean, an independent E&P company focused on developing resources in the Mediterranean and the North Sea. The work follows a successful four well offshore drilling campaign that Halliburton previously executed in the Karish and Karish North gas fields. Halliburton will collaborate with Energean to economically and safely deliver exploration, appraisal, and development wells offshore Israel. The contract is for three firm and two optional wells to deliver all services including project management, directional drilling, drill bits, drilling fluids, cementing, solids control, wireline, slickline, completions, production enhancement, and subsea services.

07:02 EDT Zimmer Biomet says Richard Heppenstall appointed as CFO of 'NewCo' - Zimmer Biomet announced key appointments to the "NewCo" leadership team, including Richard Heppenstall as Executive Vice President and CFO. Additionally, the company announced ZimVie as the name for the planned spin-off company for the Spine and Dental businesses. Zimmer Biomet announced in February 2021 its intent to form a new independent, publicly traded company to optimize resource allocation and drive toward market leadership. That transaction process remains on track, with an expected close in mid-2022. Heppenstall brings more than 25 years of broad corporate and operational finance experience to ZimVie, most recently serving as CFO of Breg, Inc., a global manufacturer and solutions provider of orthopedic braces, cold therapy and other medical equipment.

07:02 EDT Kroger, Instacart launch Kroger Delivery Now - Kroger and Instacart launched Kroger Delivery Now, a new service powered by a virtual convenience store that is fulfilled by the Kroger Family of Stores and provides customers groceries and household essentials in as fast as 30 minutes. Kroger Delivery Now's offering of 25,000 items includes doorstep delivery. With the launch of Kroger Delivery Now, Instacart is also unveiling the Convenience Hub on the Instacart Marketplace, a new product experience that streamlines convenience shopping for customers. Through the new Convenience Hub, customers in nearly every major U.S. city can now shop for convenience essentials 24 hours a day, seven days a week with free priority delivery in as fast as 30 minutes for Instacart Express members on orders over $10.

06:59 EDT NanoViricides completes licensing for Coronavirus field from TheraCour Pharma - NanoViricides announced that it has completed the process of licensing the human Coronavirus field for drug development and commercialization from TheraCour Pharma. The company executed a license agreement for the field comprising anti-viral treatments for coronavirus derived human infections with TheraCour Pharma on September 8. The licensed field includes antiviral drugs to treat SARS-CoV-2 and its variants that cause the COVID-19 disease resulting in a global pandemic that continues to rage through the world, wave after wave, as new variants develop and take hold. There was no upfront cash payment for the license and the compensation terms were generally consistent with prior licenses. NanoViricides is currently working on taking its two COVID-19 lead drug candidates, namely, NV-CoV-2- and NV-CoV-2-R, into human clinical trials. The company believes that the preclinical work is substantially complete for taking these drugs into human evaluation. The company believes that these broad-spectrum anti-coronavirus drugs will continue to be effective even as the virus continues to mutate developing into a number of variants of concern. Antibody protection afforded by vaccines and the effectiveness of antibody drugs have continued to decline progressively as new SRAS-CoV-2 variants have emerged. The company believes that its unique anti-viral nanomachine technology overcomes these issues. Under the Agreement, NanoViricides has obtained a world-wide, exclusive, sub-licensable, license to use, promote, offer for sale, import, export, sell and distribute antiviral drugs that treat human Coronavirus infections using TheraCour's proprietary as well as patented technology and intellectual property, including the new patent application. The discovery of ligands and polymer materials as well as formulations, the chemistry and chemical characterization, as well as process development and related work will be performed by TheraCour under the same compensation terms as prior agreements between the parties, with no duplication of costs allowed. NanoViricides will not make any upfront cash payments to TheraCour and has agreed to the following milestone payments to TheraCour: 100,000 shares of the Company's Series A Convertible Preferred Stock, par value $0.001 per share upon the execution of the agreement; 50,000 shares of Series A Preferred Stock after the grant of the approval of Llcensee's investigational new drug application, or its equivalent; cash payments of $1.5M after the initiation of Phase I clinical trials or its equivalent; $2M after the completion of Phase 1 Clinical Trials or its equivalent for at least one product within twelve (12) months from the date of the acceptance of the IND; $2,500,000 no later than six months after the completion of Phase 2A Clinical Trials or its equivalent for at least one product within twenty months from the date of the completion of Phase 1 or its equivalent; 100,000 shares of Series A Preferred Stock after the initiation of Phase 3 clinical trials or its equivalent and, at TheraCour's option, $5M in cash or 500,000 shares of Series A Preferred Stock, no later than six months after the completion of Phase 3 clinical trials or its equivalent for at least one product within thirty-six months from the completion of Phase 2 clinical trials or its equivalent. In addition, the company agreed to pay to TheraCour 15% of net sales of licensed products and any income from sublicensed products, consistent with previous agreements. Under the agreement, TheraCour retains the exclusive right to develop and manufacture the licensed products. The agreement contemplates that the parties will enter into a separate manufacturing and supply agreement for the commercial manufacture and supply of the drug products if and when NanoViricides intends to engage into commercialization of the drugs. The agreement provides that the Manufacturing and supply agreement would be on customary and reasonable terms, on a cost-plus basis, using a market rate based on then-current industry standards, and include customary backup manufacturing rights, as with prior agreements.

06:48 EDT KULR Technology to provide its Safe Case to Heritage Battery Recycling - KULR Technology Group announced that it will provide its KULR-Tech Safe Case to lithium-ion battery recycler Heritage Battery Recycling, or HBR, a new platform company of The Heritage Group, for the safe transportation logistics of HBR's battery collection operations across North America. Based upon successful space designed solutions for NASA that were deployed on the International Space Station for safely storing laptop lithium-ion batteries, the KULR-Tech Safe Case is one of the Company's recently leading product lines entering into commercial markets.

06:35 EDT Hecla Mining provides update on its latest exploration results - Hecla Mining Company released an update on its latest exploration results. Highlights include: Drilling at both Greens Creek and Casa Berardi is on track to replace reserves by year end. Midas exploration at the Green Racer Sinter continues to expand high-grade gold and silver mineralization for over 2,000 feet of strike and 1,250 feet of dip extent. An initial resource is expected to be announced in early 2022. Greens Creek surface exploration drilling at the Lil'Sore target intersected copper and zinc-rich zones of mineralization that are indicative of a fertile feeder stockwork zone. This mineralization is stratigraphically below the targeted mine contact indicating potential for an additional mineralized mine horizon at depth or laterally. Hollister's decline has advanced and drilling of the Hatter Graben can begin in the Q4. "While focused, our exploration efforts have spanned our three operating mines and eight of our exploration properties," said Phillips S. Baker, Jr., President and CEO. "As we have adapted to operating in a pandemic, we have been able to increase drilling and expect growth in reserves and resources. We continue to have exciting results in Nevada where at Midas we are seeing similar structural controls on high-grade mineralization at Green Racer Sinter as those observed at the mine's historically producing veins leading us to add a third drill rig and at Hollister where underground drilling will begin soon. At Greens Creek, both underground and surface drilling are giving results that should lead to reserve replacement and additional drilling in the Lil'Sore area."

06:31 EDT KalVista says FDA lifts clinical hold on Phase 2 clinical trial of KVD824 - KalVista Pharmaceuticals announced that the U.S. FDA has lifted the clinical hold on the company's Phase 2 clinical trial of KVD824 for oral prophylactic treatment of hereditary angioedema. "The execution of KOMPLETE, our Phase 2 clinical trial for KVD824 as a potential oral prophylactic therapy for HAE, is expected to accelerate now that we can also proceed at our U.S. trial sites," said Andrew Crockett, CEO of KalVista. "Progress continues worldwide, with regulatory submissions complete in all of the countries where the trial will be conducted." The previously announced clinical hold was removed after FDA review of KalVista's responses to the FDA request for further information and analysis related to certain preclinical studies of KVD824. Refinements were also made to the KVD824 Phase 2 KOMPLETE protocol. The company is working closely with study investigators and clinical trial sites to proceed with all study activities as soon as possible.

06:04 EDT Volta installs new charging stations in Fairfax, Virginia - Volta announced that it has further extended its market penetration with the installation of new charging stations at Giant Food in Virginia. The exact address of these charging stations is 10653 Braddock Rd, Fairfax, Virginia 22032.

05:21 EDT Veoneer receives updated acquisition proposal from Qualcomm for $37.00 per share - Veoneer (VNE) confirmed that it has received an updated non-binding proposal from Qualcomm (QCOM) providing for the acquisition of all of the outstanding shares of Veoneer at a price of $37.00 per share in cash, following Qualcomm's public announcement of a proposal on August 5. Veoneer is evaluating all of the terms of Qualcomm's proposal in consultation with its financial and legal advisors and will, if appropriate, engage in negotiations with Qualcomm and/or Magna (MGA). There can be no assurances that Veoneer's discussions with Qualcomm will result in a transaction that the Veoneer board of directors determines is superior to Veoneer's pending transaction with Magna. On July 22, Veoneer announced that it entered into a definitive merger agreement, approved by Veoneer's board of directors, with Magna International Inc. The merger agreement with Magna remains in full force and effect, and the board of directors of Veoneer has not withdrawn or modified its recommendation that the stockholders of Veoneer vote in favor of the approval of the merger, the merger agreement and the transactions contemplated thereby.

05:13 EDT Nyxoah receives breakthrough device designation for Genio from FDA - Nyxoah announced that the FDA has granted the Genio bilateral hypoglossal nerve stimulation system breakthrough device designation for the treatment of adult patients with moderate to severe OSA and Complete Concentric Collapse of the soft palate.

05:09 EDT iQIYI launches 'iBarca Membership' premium membership program - iQIYI announced that the company expanded its existing strategic collaboration with Barca to develop a new premium membership program, "iBarca Membership". As Barca's first certificated digital membership product launched in China, the "iBarca Membership" enables fans in China to watch all La Liga games in the 2021/22 season and enjoy a range of exclusive privileges. iQIYI at present holds the rights to La Liga until 2029, and the "iBarca Membership" will be valid for the duration of the 2021/22 season. In addition to game viewing rights with multilingual commentary, subscribers will enjoy exclusive video content courtesy of Barca TV, available for the first time in Mandarin, giving fans in China access to hours of exclusive club content that includes documentaries and interviews with players. Other privileges include one free ticket and additional half-priced tickets to the Barca Experience in Haikou, 10% off merchandise using Haikou Barca Experience WeChat mini-program, and discounted La Liga tickets at the Camp Nou. New subscribers will also receive a FC Barcelona merchandise from the Haikou Barca Mission Hills store as a welcome gift.